pCAG/hTAZ-FL
(Plasmid
#139979)
-
PurposeExpresses full length human Tafazzin with codon modified for cloning. Transgene flanked by AAV2 ITR
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 139979 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backboneAAV2/9.cTnT.PI.EGFP.RBG
-
Backbone manufacturerPenn Vector Core
- Backbone size w/o insert (bp) 4187
- Total vector size (bp) 5859
-
Vector typeAAV
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameFull length human Tafazzin
-
SpeciesH. sapiens (human)
-
Insert Size (bp)887
-
GenBank IDNM_000116.5
-
Entrez GeneTAFAZZIN (a.k.a. BTHS, CMD3A, EFE, EFE2, G4.5, LVNCX, TAZ, Taz1)
- Promoter CAG
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site AGEI (unknown if destroyed)
- 3′ cloning site HINDIII (unknown if destroyed)
- 5′ sequencing primer GATGCCTCTGCACGTGAA (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCAG/hTAZ-FL was a gift from William Pu (Addgene plasmid # 139979 ; http://n2t.net/addgene:139979 ; RRID:Addgene_139979) -
For your References section:
AAV Gene Therapy Prevents and Reverses Heart Failure in A Murine Knockout Model of Barth Syndrome. Wang S, Li Y, Xu Y, Ma Q, Lin Z, Schlame M, Bezzerides VJ, Strathdee D, Pu WT. Circ Res. 2020 Mar 9. doi: 10.1161/CIRCRESAHA.119.315956. 10.1161/CIRCRESAHA.119.315956 PubMed 32146862